Statistik Asas
| LEI | XQ0331QX53IRX25OY417 |
| CIK | 1364099 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Innophos Holdings, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| February 18, 2020 |
IPHS / Innophos Holdings, Inc. 15-12B - - 15-12B 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-33124 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specif |
|
| February 12, 2020 |
IPHS / Innophos Holdings, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* INNOPHOS HOLDINGS INC (Name of Issuer) Common Stock (Title of Class of Securities) 45774N108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S |
|
| February 12, 2020 |
IPHS / Innophos Holdings, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 7, 2020 |
IPHS / Innophos Holdings, Inc. S-8 POS - - S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 7, 2020 Registration No. |
|
| February 7, 2020 |
IPHS / Innophos Holdings, Inc. S-8 POS - - S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 7, 2020 Registration No. |
|
| February 7, 2020 |
Amended and Restated By-laws of Innophos Holdings, Inc. EX-3.2 3 d865894dex32.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF INNOPHOS HOLDINGS, INC. A Delaware Corporation ARTICLE I OFFICES Section 1.1 Registered Office. The registered office of the corporation in the State of Delaware shall be located at 251 Little Falls Drive, in the City of Wilmington, County of New Castle. The name of the Corporation’s registered agent at such address shall |
|
| February 7, 2020 |
Third Amended and Restated Certificate of Incorporation of Innophos Holdings, Inc. EX-3.1 Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INNOPHOS HOLDINGS, INC. FIRST: The name of the corporation is Innophos Holdings, Inc. (the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is Corporation Service Company, 251 Little Falls Drive, in the City of Wilmington, County of New Castle, Delaware 19808. The n |
|
| February 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 7, 2020 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commission |
|
| February 7, 2020 |
EX-99.1 Exhibit 99.1 ONE ROCK CAPITAL PARTNERS COMPLETES ACQUISITION OF INNOPHOS Richard Hooper Appointed Chief Executive Officer CRANBURY, NJ and NEW YORK, NY, February 7, 2020 – Innophos Holdings, Inc. (“Innophos” or the “Company”), a leading international producer of essential ingredients, today announced the completion of its acquisition by an affiliate of One Rock Capital Partners, LLC (“One |
|
| February 7, 2020 |
IPHS / Innophos Holdings, Inc. S-8 POS - - S-8 POS S-8 POS As filed with the Securities and Exchange Commission on February 7, 2020 Registration No. |
|
| February 6, 2020 |
IPHS / Innophos Holdings, Inc. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Innophos Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 45774N108 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and |
|
| January 22, 2020 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 22, 2020 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commission |
|
| January 15, 2020 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 15, 2020 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commission |
|
| January 15, 2020 |
Innophos Stockholders Approve Acquisition by One Rock Capital Partners EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] Innophos Stockholders Approve Acquisition by One Rock Capital Partners CRANBURY, New Jersey – (January 15, 2020) – Innophos Holdings, Inc. (“Innophos” or the “Company”) (NASDAQ:IPH |
|
| December 6, 2019 |
IPHS / Innophos Holdings, Inc. DEFM14A - - DEFM14A DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 14, 2019 |
IPHS / Innophos Holdings, Inc. PREM14A - - PREM14A PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 6, 2019 |
INNOPHOS HOLDINGS, INC. REPORTS THIRD-QUARTER 2019 RESULTS EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. REPORTS THIRD-QUARTER 2019 RESULTS CRANBURY, New Jersey - (November 6, 2019) - Innophos Holdings, Inc. (NASDAQ: IPHS) today announced financial results for |
|
| November 6, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 6, 2019 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commission |
|
| November 6, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Num |
|
| October 21, 2019 |
EX-2.1 2 d87713dex21.htm EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among Iris Parent LLC, Iris Merger Sub 2019, Inc. and Innophos Holdings, Inc. Dated as of October 20, 2019 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS & INTERPRETATIONS 1 1.1 Certain Definitions 1 1.2 Additional Definitions 12 1.3 Certain Interpretations 14 ARTICLE II THE MERGER 16 2.1 The Merger 16 |
|
| October 21, 2019 |
Communication to Employees, dated October 21, 2019 EX-99.2 Exhibit 99.2 PRIVATE & CONFIDENTIAL Innophos FAQs for Employees Can you explain the announcement that was made today? We announced that Innophos has entered into a definitive agreement with an affiliate of One Rock Capital Partners, a leading middle market private equity firm. Under the terms of the agreement One Rock will acquire all of Innophos’ outstanding shares and become the new owne |
|
| October 21, 2019 |
IPHS / Innophos Holdings, Inc. DEFA14A - - DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 19, 2019 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Co |
|
| October 21, 2019 |
Press Release, dated October 21, 2019 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] Innophos Enters into Definitive Agreement to Be Acquired by One Rock Capital Partners for $32.00 per Share Announces Preliminary Q3 2019 Results CRANBURY, New Jersey – (October 21, |
|
| October 21, 2019 |
Amendment to Innophos Holdings, Inc.’s Amended and Restated Bylaws, dated as of October 19, 2019 EX-3.1 Exhibit 3.1 AMENDMENT TO AMENDED AND RESTATED BYLAWS OF INNOPHOS HOLDINGS, INC. (Adopted and effective as of October 19, 2019) The Amended and Restated Bylaws of Innophos Holdings, Inc. are hereby amended to add a new Article VIII, as set forth below: ARTICLE VIII FORUM FOR ADJUDICATION OF DISPUTES Unless the Corporation consents in writing to the selection of an alternative forum, and to t |
|
| October 21, 2019 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] Innophos Enters into Definitive Agreement to Be Acquired by One Rock Capital Partners for $32.00 per Share Announces Preliminary Q3 2019 Results CRANBURY, New Jersey – (October 21, |
|
| October 21, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 19, 2019 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commission |
|
| October 21, 2019 |
Amendment to Innophos Holdings, Inc.’s Amended and Restated Bylaws, dated as of October 19, 2019 EX-3.1 Exhibit 3.1 AMENDMENT TO AMENDED AND RESTATED BYLAWS OF INNOPHOS HOLDINGS, INC. (Adopted and effective as of October 19, 2019) The Amended and Restated Bylaws of Innophos Holdings, Inc. are hereby amended to add a new Article VIII, as set forth below: ARTICLE VIII FORUM FOR ADJUDICATION OF DISPUTES Unless the Corporation consents in writing to the selection of an alternative forum, and to t |
|
| October 21, 2019 |
EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among Iris Parent LLC, Iris Merger Sub 2019, Inc. and Innophos Holdings, Inc. Dated as of October 20, 2019 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS & INTERPRETATIONS 1 1.1 Certain Definitions 1 1.2 Additional Definitions 12 1.3 Certain Interpretations 14 ARTICLE II THE MERGER 16 2.1 The Merger 16 2.2 The Effective Time 16 |
|
| October 21, 2019 |
PRIVATE & CONFIDENTIAL Innophos FAQs for Employees EX-99.2 5 d87713dex992.htm EX-99.2 Exhibit 99.2 PRIVATE & CONFIDENTIAL Innophos FAQs for Employees Can you explain the announcement that was made today? We announced that Innophos has entered into a definitive agreement with an affiliate of One Rock Capital Partners, a leading middle market private equity firm. Under the terms of the agreement One Rock will acquire all of Innophos’ outstanding sha |
|
| August 8, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0 |
|
| August 6, 2019 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. REPORTS SECOND-QUARTER 2019 RESULTS Pricing Power, Cost Actions and Mix Shift Offset Topline Pressures to Drive Margin Growth and Benefit Bottom Line Perfor |
|
| August 6, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2019 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commissi |
|
| May 15, 2019 |
Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2019 (May 14, 2019) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporati |
|
| May 1, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number |
|
| April 30, 2019 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. REPORTS FIRST-QUARTER 2019 RESULTS Ongoing Price Increases and Cost Actions Benefit Bottom Line Performance Continued Success with Transition to Lower Cost |
|
| April 30, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 30, 2019 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commissi |
|
| April 8, 2019 |
IPHS / Innophos Holdings, Inc. DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 4, 2019 |
Form of Award Agreement under the 2018 LTIP (all participants, other than Dr. Kim Ann Mink) EX-10.1 2 d673856dex101.htm EX-10.1 Exhibit 10.1 LONG-TERM INCENTIVE AWARD AGREEMENT (Including Confidentiality, Non-Competition and Non-Solicitation Covenants) This LONG-TERM INCENTIVE AWARD AGREEMENT (“Agreement”) made as of the date shown below by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereof (the “Participant” |
|
| April 4, 2019 |
Form of Award Agreement under the 2018 LTIP (Dr. Kim Ann Mink) EX-10.2 Exhibit 10.2 LONG-TERM INCENTIVE AWARD AGREEMENT (Including Confidentiality, Non-Competition and Non-Solicitation Covenants) This LONG-TERM INCENTIVE AWARD AGREEMENT (“Agreement”) made as of the date shown below by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereof (the “Participant”). Introductory Statement Th |
|
| April 4, 2019 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2019 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commissio |
|
| March 15, 2019 |
EX-99.1 2 d720504dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Mark Feuerbach Innophos 609-366-1204 Media Contact Ryan Flaim Sharon Merrill Associates 617-542-5300 INNOPHOS HOLDINGS, INC. ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION Mark Feuerbach Appointed as Interim Chief Financial Officer CRANBURY, New Jersey – (March 15, 2019) – Innophos Holdings, Inc. (NASDAQ: IPHS) t |
|
| March 15, 2019 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 15, 2019 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commissi |
|
| February 27, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to INNOPHOS HOLDINGS, INC. |
|
| February 27, 2019 |
Exhibit 10.21 INDEMNIFICATION AGREEMENT This Indemnification Agreement ("Agreement") is made as of , by and between Innophos Holdings, Inc., a Delaware corporation (the "Company"), and the undersigned individual ("Indemnitee"). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement. RECITALS WHEREAS, t |
|
| February 27, 2019 |
Management Incentive Plan Innophos, Inc. Exhibit 10.19 Management Incentive Plan Innophos, Inc. Effective 1/1/2018 Purpose The Management Incentive Plan (the “Plan”) is designed to promote the interests of Innophos, Inc. and certain of its corporate affiliates (collectively, the “Corporation”) by providing senior executives, managers and other key employees with incentives and rewards commensurate with the achievement of the business and |
|
| February 27, 2019 |
SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. EXHIBIT 21.1 SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. Company Ownership* Jurisdiction Innophos Investments Holdings, Inc. Innophos Holdings, Inc. Delaware Innophos, Inc. Innophos Investments Holdings, Inc. Delaware Woody IV, LLC Innophos Investments Holdings, Inc. Utah Innophos Nutrition, Inc. Innophos, Inc. Delaware Innophos (Gibraltar) Investments Holdings Limited Innophos, Inc. Gibraltar Novel I |
|
| February 27, 2019 |
Exhibit 10.27 CHANGE IN CONTROL AGREEMENT This CHANGE OF CONTROL AGREEMENT (the “Agreement”), dated April 26, 2017 (the “Effective Date”), by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and Mark Santangelo (the “Executive”). RECITAL Whereas, it is in the best interests of the Company and its subsidiaries to encourage Executive to continue the Executive’s career and |
|
| February 27, 2019 |
INNOPHOS, INC. RETIREMENT SAVINGS RESTORATION PLAN Exhibit 10.18 INNOPHOS, INC. RETIREMENT SAVINGS RESTORATION PLAN Active 39171720.2 1 INNOPHOS, INC. RETIREMENT SAVINGS RESTORATION PLAN Table of Contents Page Article 1 - Definitions 1 1.1 Account. 1 1.2 Administrator. 1 1.3 Board. 1 1.4 Change-in-Control. 1 1.5 Code. 2 1.6 Compensation. 2 1.7 Disability. 3 1.8 Effective Date. 3 1.9 Eligible Employee. 4 1.1 Employee. 4 1.11 Employer. 4 1.12 Employ |
|
| February 20, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d711421d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 20, 2019 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdictio |
|
| February 20, 2019 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Mark Feuerbach Innophos 609-366-1204 [email protected] Media Contact Ryan Flaim Sharon Merrill Associates 617-542-5300 [email protected] INNOPHOS HOLDINGS, INC. REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS Delivered Top and Bottom Line Results in Line with Expectations Double Digit Year-on-Year Revenue Growth i |
|
| February 11, 2019 |
IPHS / Innophos Holdings, Inc. / VANGUARD GROUP INC Passive Investment innophosholdingsinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10 )* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropria |
|
| February 8, 2019 |
IPHS / Innophos Holdings, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment SC 13G/A 1 dfs078.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* INNOPHOS HOLDINGS INC (Name of Issuer) Common Stock (Title of Class of Securities) 45774N108 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| November 19, 2018 |
8-K 1 d655631d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 19, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdictio |
|
| November 19, 2018 |
Innophos Holdings, Inc. Elects Jane Hilk to the Board of Directors EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] Innophos Holdings, Inc. Elects Jane Hilk to the Board of Directors CRANBURY, New Jersey – (November 19, 2018) – The Board of Directors of Innophos Holdings, Inc. (NASDAQ: IPHS), a |
|
| November 1, 2018 |
8-K 1 d646408d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 1, 2018 (October 29, 2018) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or |
|
| November 1, 2018 |
EX-99.1 3 d646408dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Mark Feuerbach Innophos 609-366-1204 [email protected] Media Contact Ryan Flaim Sharon Merrill Associates 617-542-5300 [email protected] INNOPHOS HOLDINGS, INC. REPORTS THIRD-QUARTER 2018 RESULTS Sales of $197 million consistent with previously issued preliminary results and up 7% versus |
|
| November 1, 2018 |
EX-10.1 Exhibit 10.1 Confidential Treatment Requested by Innophos Holdings, Inc. Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. PURIFIED PHOSPHORIC ACID (PPA) SUPPLY CONTRACT This SUPPLY CONTRACT (including the General Terms and Conditions and each e |
|
| November 1, 2018 |
IPHS / Innophos Holdings, Inc. 10-Q (Quarterly Report) 10-Q 1 iphs10q093018.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period |
|
| October 16, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d638055d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 16, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction |
|
| October 16, 2018 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. ISSUES PRELIMINARY THIRD-QUARTER RESULTS AND UPDATES FULL YEAR 2018 GUIDANCE Remains on Path to Double Digit Year-On-Year Revenue Growth Continues Price Act |
|
| September 27, 2018 |
Form of Restricted Stock Agreement under the Innophos Holdings, Inc. 2018 Long-Term Incentive Plan EX-10.1 2 d624089dex101.htm EX-10.1 Exhibit 10.1 LONG TERM INCENTIVE AWARD AGREEMENT (Including Confidentiality, Non-Competition and Non-Solicitation Covenants) [Date] This LONG TERM INCENTIVE AWARD AGREEMENT (“Agreement”) made as of the date shown below by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereof (the “Parti |
|
| September 27, 2018 |
8-K 1 d624089d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 27, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdicti |
|
| July 31, 2018 |
IPHS / Innophos Holdings, Inc. 10-Q (Quarterly Report) 10-Q 1 iphs10q063018.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| July 30, 2018 |
EX-99.1 2 d591661dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. REPORTS SECOND-QUARTER 2018 RESULTS Continued Revenue Growth in FHN Segment Driven by Strength in Legacy and Acquired Portfolios |
|
| July 30, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d591661d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of |
|
| July 2, 2018 |
EX-10.4 Exhibit 10.4 Execution Version SERVICES AGREEMENT by and between PCS NITROGEN FERTILIZER, L.P. and INNOPHOS, INC. Dated as of June 29, 2018 This SERVICES AGREEMENT (together with the Schedules hereto, this “Agreement”), dated as of June 29, 2018 (the “Signing Date”), is by and between PCS Nitrogen Fertilizer, L.P., a Delaware limited partnership (“PCS”), and Innophos, Inc., a Delaware corp |
|
| July 2, 2018 |
EX-99.1 Exhibit 99.1 Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] FOR IMMEDIATE RELEASE Innophos Announces New Purified Phosphoric Acid (“PPA”) Supply Agreement with Nutrien Ensures Security of Supply for Specialty Phosphate Product Portfolio Demonstrates Continued Co |
|
| July 2, 2018 |
EX-10.3 4 d834549dex103.htm EX-10.3 Confidential Treatment Requested by Innophos Holdings, Inc. Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. Exhibit 10.3 Execution Version MERCHANT GREEN ACID SUPPLY AGREEMENT This Agreement (this “Agreement”), date |
|
| July 2, 2018 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2018 (June 29, 2018) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of inco |
|
| July 2, 2018 |
EX-10.1 2 d834549dex101.htm EX-10.1 Confidential Treatment Requested by Innophos Holdings, Inc. Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. Exhibit 10.1 Execution Version TERMINATION AGREEMENT THIS TERMINATION AGREEMENT (this “Agreement”) is made |
|
| July 2, 2018 |
EX-10.6 7 d834549dex106.htm EX-10.6 Confidential Treatment Requested by Innophos Holdings, Inc. Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. Exhibit 10.6 Execution Version PURIFIED WET PHOSPHORIC ACID SUPPLY AGREEMENT This Agreement (this “Agreemen |
|
| July 2, 2018 |
EX-99.2 Exhibit 99.2 Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] FOR IMMEDIATE RELEASE Innophos Advances Strategic Value Chain Repositioning Initiative with Additional Milestone Strategic Sourcing Arrangements Initiative Expected to Deliver 10% Adjusted Diluted EPS I |
|
| July 2, 2018 |
Letter Agreement between Innophos, Inc. and PCS Nitrogen Fertilizer, L.P., dated June 29, 2018 EX-10.5 6 d834549dex105.htm EX-10.5 Exhibit 10.5 PCS Nitrogen Fertilizer, L.P. 1101 Skokie Blvd, Suite 400 Northbrook, IL 60062 June 29, 2018 Innophos, Inc. 259 Prospect Plains Road, Building A Cranbury, NJ 08512 Attention: Kim Ann Mink, Ph.D. Dear Ms. Mink: Reference is hereby made to that certain Services Agreement (the “Services Agreement”), dated as of the date hereof, by and between PCS Nitro |
|
| July 2, 2018 |
EX-10.2 Exhibit 10.2 Execution Version ADDENDUM TO THE AMENDED AND RESTATED ACID PURCHASE AGREEMENT This Addendum (the “Addendum”) to the Amended and Restated Acid Purchase Agreement, dated March 23, 2000 (the “MGA Supply Agreement”), is entered into and effective as of June 29, 2018 (the “Effective Date”) among Innophos, Inc., a Delaware corporation, as the successor in interest under the Agreeme |
|
| June 6, 2018 |
IPHS / Innophos Holdings, Inc. FORM S-8 S-8 1 d598044ds8.htm FORM S-8 As filed with the Securities and Exchange Commission on June 6, 2018 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-1380758 (State or Other Jurisdiction of Incorporati |
|
| May 16, 2018 |
8-K 1 d589629d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of |
|
| May 16, 2018 |
Innophos Holdings, Inc. 2018 Long-Term Incentive Plan. EX-10.1 Exhibit 10.1 INNOPHOS HOLDINGS, INC. 2018 Long-Term Incentive Plan 1. Plan. This Innophos Holdings, Inc. 2018 Long-Term Incentive Plan (this “Plan”) was adopted by Innophos Holdings, Inc. to reward and provide incentives to certain employees and directors by enabling them to acquire awards related to shares of common stock of Innophos Holdings, Inc. 2. Definitions. As used herein, the term |
|
| May 9, 2018 |
IPHS / Innophos Holdings, Inc. 10-Q (Quarterly Report) 10-Q 1 iphs10q033118.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro |
|
| May 1, 2018 |
EX-99.1 2 d575086dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. REPORTS FIRST-QUARTER 2018 RESULTS Revenue Growth in Both Legacy and Acquired Businesses Generated Solid Earnings Ahead of Expec |
|
| May 1, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d575086d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of i |
|
| April 11, 2018 |
IPHS / Innophos Holdings, Inc. DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 10, 2018 |
IPHS / Innophos Holdings, Inc. / VANGUARD GROUP INC Passive Investment SC 13G/A 1 innophosholdingsinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9 )* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: March 29, 2018 Check the appropriate box to designate the rule pursuant |
|
| April 4, 2018 |
Form of Award Agreement under the 2009 LTIP (Dr. Kim Ann Mink) EX-10.2 3 d527224dex102.htm EX-10.2 Exhibit 10.2 LONG TERM INCENTIVE AWARD AGREEMENT (Including Confidentiality, Non-Competition and Non-Solicitation Covenants) [Year] This LONG TERM INCENTIVE AWARD AGREEMENT (“Agreement”) made as of the date shown below by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereof (the “Parti |
|
| April 4, 2018 |
Form of Award Agreement under the 2009 LTIP (all participants, other than Dr. Kim Ann Mink) EX-10.1 2 d527224dex101.htm EX-10.1 Exhibit 10.1 LONG TERM INCENTIVE AWARD AGREEMENT (Including Confidentiality, Non-Competition and Non-Solicitation Covenants) [Year] This LONG TERM INCENTIVE AWARD AGREEMENT (“Agreement”) made as of the date shown below by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereof (the “Parti |
|
| April 4, 2018 |
8-K 1 d527224d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 2, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of |
|
| March 29, 2018 |
8-K 1 d548587d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 26, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction o |
|
| March 1, 2018 |
EXHIBIT 10.20 CHANGE IN CONTROL AGREEMENT This CHANGE OF CONTROL AGREEMENT (the “Agreement”), dated July 15, 2016 (the “Effective Date”), by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and Sherry Duff (the “Executive”). Recital Whereas, it is in the best interests of the Company and its subsidiaries to encourage Executive to continue the Executive’s career and serv |
|
| March 1, 2018 |
IPHS / Innophos Holdings, Inc. 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to INNOPHOS HOLDINGS, INC. |
|
| March 1, 2018 |
Exhibit 12.1 Calculation of Ratio of Earnings to Fixed Charges December 31, (dollars in thousands) 2017 2016 2015 2014 2013 Earnings Income before provision for income taxes $ 56,637 $ 70,318 $ 40,123 $ 97,356 $ 76,247 Plus: fixed charges (1) 9,561 10,032 9,869 6,617 7,583 $ 66,198 $ 80,350 $ 49,992 $ 103,973 $ 83,830 Fixed Charges: Gross interest expense 7,132 7,722 7,583 4,394 5,475 Estimate of |
|
| March 1, 2018 |
EXECUTIVE EMPLOYMENT AGREEMENT EXHIBIT 10.18 EXECUTIVE EMPLOYMENT AGREEMENT AGREEMENT, dated April 1, 2016 (the “Agreement”), by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and Hermanus (Han) Kieftenbeld (the “Executive”). Recital Whereas, it is in the best interests of the Company and its subsidiaries to provide the Executive with the compensation and benefits as provided herein in order to ret |
|
| March 1, 2018 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-10.19 3 iphs10k123117ex1019.htm EXHIBIT 10.19 EXHIBIT 10.19 EXECUTIVE EMPLOYMENT AGREEMENT AGREEMENT, dated October 7, 2016 (the “Agreement”), by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and Joshua Shane Horenstein (the “Executive”). Recital Whereas, it is in the best interests of the Company and its subsidiaries to provide the Executive with the compensation |
|
| March 1, 2018 |
SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. EXHIBIT 21.1 SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. Company Ownership* Jurisdiction Innophos Investments Holdings, Inc. Innophos Holdings, Inc. Delaware Innophos, Inc. Innophos Investments Holdings, Inc. Delaware Woody IV, LLC Innophos Investments Holdings, Inc. Utah Innophos Nutrition, Inc. Innophos, Inc. Delaware Innophos (Gibraltar) Investments Holdings Limited Innophos, Inc. Gibraltar Novel I |
|
| February 22, 2018 |
EX-99.1 2 d537276dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS Significant Progress Advancing Vision 2022 Strategy 2017 Revenue and Earnings |
|
| February 22, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d537276d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 21, 2018 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdictio |
|
| February 12, 2018 |
8-K 1 d538671d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 12, 2018 (February 8, 2018) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State |
|
| February 12, 2018 |
EX-3.1 Exhibit 3.1 BYLAWS OF INNOPHOS HOLDINGS, INC. A Delaware Corporation (Amended and Restated as of February 8, 2018) ARTICLE I OFFICES Section 1. Registered Office. The registered office and registered agent of Innophos Holdings, Inc. (the ?Corporation?) shall be as set forth in the Certificate of Incorporation of the Corporation, as it may be amended and/or restated from time to time (the ?C |
|
| February 12, 2018 |
Blackline of Amended and Restated Bylaws (showing changes adopted as of February 8, 2018) EX-3.2 3 d538671dex32.htm EX-3.2 Exhibit 3.2 BYLAWS OF INNOPHOS HOLDINGS, INC. A Delaware Corporation (Amended and Restated as of February 58, 20168) ARTICLE I OFFICES Section 1. Registered Office. The registered office and registered agent of Innophos Holdings, Inc. (the “Corporation”) in the State of Delaware shall be located at 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808. The n |
|
| February 9, 2018 |
IPHS / Innophos Holdings, Inc. / VANGUARD GROUP INC Passive Investment SC 13G/A 1 innophosholdingsinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8 )* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to designate the rule pursu |
|
| February 9, 2018 |
IPHS / Innophos Holdings, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G Passive Investment SC 13G 1 dfs074.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* INNOPHOS HOLDINGS INC (Name of Issuer) Common Stock (Title of Class of Securities) 45774N108 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| October 31, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 31, 2017 (October 31, 2017) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jur |
|
| October 31, 2017 |
EX-99.1 2 q317earningsprfinal.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. REPORTS THIRD-QUARTER 2017 RESULTS Q3 Earnings Performance Exceeds Expectations Novel Ingredients Integration Progressing as Plann |
|
| October 31, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 iphs10q093017.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period |
|
| October 2, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 30, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commissi |
|
| September 8, 2017 |
IPHS / Innophos Holdings, Inc. / VANGUARD GROUP INC Passive Investment innophosholdingsinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7 )* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: August 31, 2017 Check the appropriate |
|
| August 28, 2017 |
EX-99.1 2 d423812dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS COMPLETES ACQUISITION OF NOVEL INGREDIENTS CREATING A NEARLY $0.5 BILLION FOOD, HEALTH AND NUTRITION PLATFORM CRANBURY, New Jersey – (August 28 |
|
| August 28, 2017 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 28, 2017 (August 25, 2017) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of |
|
| August 1, 2017 |
EX-99.2 4 d398635dex992.htm EX-99.2 REVITALIZED FOR GROWTH NOVEL INGREDIENTS ACQUISITION August 1, 2017 – 9:00 am ET Exhibit 99.2 Forward-Looking Statements This presentation contains or may contain forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The company intends these for |
|
| August 1, 2017 |
EX-99.1 3 d398635dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS TO ACQUIRE NOVEL INGREDIENTS TO CREATE A NEARLY $0.5 BILLION FOOD, HEALTH AND NUTRITION PLATFORM Advances Vision 2022 Growth Strategy and Enhan |
|
| August 1, 2017 |
EX-10.1 2 d398635dex101.htm EX-10.1 Table of Contents Exhibit 10.1 Execution Version AGREEMENT AND PLAN OF MERGER Dated as of July 28, 2017 by and among INNOPHOS HOLDINGS, INC., THOR MERGER SUB, INC., GENNX NOVEL HOLDING, INC. and GENNX NOVEL REPRESENTATIVE, LLC as the Shareholders’ Representative Table of Contents TABLE OF CONTENTS Page ARTICLE I DEFINED TERMS 1 Section 1.01 Certain Definitions 1 |
|
| August 1, 2017 |
8-K 1 d398635d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 1, 2017 (July 28, 2017) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or othe |
|
| August 1, 2017 |
EX-99.1 2 d425935dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Investor Contact Media Contact Mark Feuerbach Ryan Flaim Innophos Sharon Merrill Associates 609-366-1204 617-542-5300 [email protected] [email protected] INNOPHOS HOLDINGS, INC. REPORTS SECOND-QUARTER 2017 RESULTS Q2 Revenue and Earnings Performance Exceeds Guidance Positive Volume Trends and Operational |
|
| August 1, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 1, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commission F |
|
| August 1, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0 |
|
| June 13, 2017 |
Innophos Holdings 10-K/A (Annual Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K/A Amendment No. |
|
| June 13, 2017 |
CORRESP 1 filename1.htm June 13, 2017 Mr. Terence O’Brien Accounting Branch Chief Division of Corporation Finance Securities and Exchange Commission Washington, D.C. 20549-4631 Innophos Holdings, Inc. Form 10-K for Fiscal Year Ended December 31, 2016 Filed February 28, 2017 Form 8-K Filed May 1, 2017 File No. 1-33124 Response to Staff Comment Letter dated June 5, 2017 Dear Mr. O’Brien: This letter |
|
| June 6, 2017 |
Innophos Holdings FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 1, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commi |
|
| June 6, 2017 |
EX-10.1 2 d393273dex101.htm EX-10.1 Exhibit 10.1 CHANGE IN CONTROL AGREEMENT This CHANGE OF CONTROL AGREEMENT (the “Agreement”), dated June 1, 2017 (the “Effective Date”), by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and Amy Hartzell (the “Executive”). RECITAL Whereas, it is in the best interests of the Company and its subsidiaries to encourage Executive to conti |
|
| May 18, 2017 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 16, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 16, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 16, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Commi |
|
| May 16, 2017 |
EX-99.1 2 a2016quarterlysegmentinfor.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. RELEASES 2016 QUARTERLY RESULTS REFLECTING PREVIOUSLY ANNOUNCED NEW OPERATING SEGMENTS CRANBURY, New Jersey – (May 16, 2017) – Innophos Holdings, Inc. (NASDAQ: IPHS), today publicized its 2016 quarterly segment results according to the new operating segments that were implemented in the first quarte |
|
| May 2, 2017 |
Innophos Holdings 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number |
|
| May 1, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 form8-kq12017earnings.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdictio |
|
| May 1, 2017 |
Exhibit FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS FIRST QUARTER 2017 RESULTS Improved Margin Profile Driven by Cost Controls and Favorable Product Mix Continued Progress Advancing Three Strategic Pillars of Operational Excellence, Commercial Excellence and Strategic Growth in Support of Vision 2022 CRANBURY, New Jersey ? (May 1, 2017) ? Innophos Holdings, Inc. (NASDAQ: IPHS), today ann |
|
| April 27, 2017 |
8-K 1 form8-kmarkandyasef.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 27, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdicti |
|
| April 27, 2017 |
Exhibit FOR IMMEDIATE RELEASE Innophos Holdings, Inc. Appoints Seasoned Global Operations Executive Mark Santangelo As Senior Vice President, Manufacturing, Engineering, and EH&S CRANBURY, New Jersey ? (April 27, 2017) ? Innophos Holdings, Inc. (NASDAQ: IPHS) today announced that its Board of Directors has appointed Mark Santangelo as Senior Vice President, Manufacturing, Engineering, and EH&S eff |
|
| April 7, 2017 |
8-K 1 form8-kltipgrants.htm 8-K LTIP AWARDS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 3, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other |
|
| April 7, 2017 |
EX-10.1 2 exhibit101.htm EXHIBIT 10.1 LONG TERM INCENTIVE AWARD AGREEMENT (Including Confidentiality, Non-Competition and Non-Solicitation Covenants) [Date] This LONG TERM INCENTIVE AWARD AGREEMENT (“Agreement”) made as of the date shown below by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereof (the “Participant”). I |
|
| April 5, 2017 |
8-K 1 d287308d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 5, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction o |
|
| April 5, 2017 |
EX-99.1 2 d287308dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Innophos Unveils “Vision 2022: The Path to Revitalized Growth” Targeting $1.25 Billion Revenue and 20% Adjusted EBITDA by 2022 Reiterates Q1 2017 Expectations and 2017 Guidance Company to Webcast Investor Day Beginning at 8:30 a.m. ET CRANBURY, New Jersey – (April 5, 2017) – Innophos Holdings, Inc. (NASDAQ: IPHS) today announce |
|
| April 5, 2017 |
EX-99.2 3 d287308dex992.htm EX-99.2 2017 INVESTOR DAY New York City | April 5, 2017 REVITALIZED FOR GROWTH Exhibit 99.2 Page MARK FEUERBACH VP Investor Relations, Treasury, FP&A Joined Innophos: April 1989 Industry experience: 28 years 2017 Investor Day, New York City | April 5, 2017 Safe Harbor During the course of this presentation, management may make forward-looking statements regarding financ |
|
| April 3, 2017 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Pro |
|
| April 3, 2017 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| February 28, 2017 |
Innophos Holdings 10-K (Annual Report) 10-K 1 iphs10k123116.htm 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to INNOPHOS HOLDING |
|
| February 28, 2017 |
EXECUTIVE EMPLOYMENT AGREEMENT EXHIBIT 10.20 EXECUTIVE EMPLOYMENT AGREEMENT AGREEMENT, dated as of the Effective Date specified below (this “Agreement”) by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and Jean Marie Mainente (the “Executive”). Recitals 1.The Executive has been employed by the Company since July 28, 2015. 2.The Executive has been duly appointed and is serving as the Company’s Vice |
|
| February 28, 2017 |
Exhibit 12.1 Calculation of Ratio of Earnings to Fixed Charges December 31, (dollars in thousands) 2016 2015 2014 2013 2012 Earnings Income before provision for income taxes $ 70,318 $ 40,123 $ 97,356 $ 76,247 $ 105,973 Plus: fixed charges (1) 10,032 9,869 6,617 7,583 8,099 $ 80,350 $ 49,992 $ 103,973 $ 83,830 $ 114,072 Fixed Charges: Gross interest expense 7,722 7,583 4,394 5,475 6,042 Estimate o |
|
| February 28, 2017 |
LONG TERM INCENTIVE AWARD AGREEMENT EXHIBIT 10.13 LONG TERM INCENTIVE AWARD AGREEMENT This LONG TERM INCENTIVE AWARD AGREEMENT (“Agreement”) made as of the date shown below by and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereof (“the Participant”). Introductory Statement This Agreement sets forth the terms and conditions under which the Participant is awa |
|
| February 28, 2017 |
EXHIBIT 10.9 THIS AMENDMENT AGREEMENT TO A CERTAIN PARTIAL ASSIGNMENT OF RIGHTS AND DUTIES AGREEMENT APICOA01-032/2013 IS ENTERED INTO BY AND BETWEEN ADMINISTRACIÓN PORTUARIA INTEGRAL DE COATZACOALCOS S.A. DE C.V., HEREIN REPRESENTED BY DR. OVIDIO NOVAL NICOLAU, IN HIS CAPACITY AS CHIEF EXECUTIVE OFFICER, PARTY OF THE FIRST PART, AND INNOPHOS FOSFATADOS DE MÉXICO, S. DE R.L. DE C.V., HEREIN REPRES |
|
| February 28, 2017 |
SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. EXHIBIT 21.1 SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. Company Ownership* Jurisdiction Innophos Investments Holdings, Inc. Innophos Holdings, Inc. Delaware Innophos, Inc. Innophos Investments Holdings, Inc. Delaware Woody IV, LLC Innophos Investments Holdings, Inc. Utah Innophos Nutrition, Inc. Innophos, Inc. Delaware Innophos (Gibraltar) Investments Holdings Limited Innophos, Inc. Gibraltar Innopho |
|
| February 21, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 21, 2017 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) |
|
| February 21, 2017 |
Exhibit FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2016 RESULTS Margins Improved on Disciplined Cost Controls Working Capital Reduction Drove Sizeable Cash Generation Significant Progress Advancing Three Strategic Pillars of Operational Excellence, Commercial Excellence and Strategic Growth CRANBURY, New Jersey ? (February 21, 2017) ? Innophos Holdings, Inc. |
|
| February 10, 2017 |
Innophos Holdings 3G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A 1 innophosholdingsinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6 )* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to designate the rule pursu |
|
| December 22, 2016 |
INNOPHOS ENTERS INTO EXPANDED $450 MILLION SENIOR SECURED BANK CREDIT FACILITY EX-99.1 Exhibit 99.1 Investor Contact Mark Feuerbach Innophos 609-366-1204 [email protected] Media Contact Ryan Flaim Sharon Merrill Associates 617-542-5300 [email protected] FOR IMMEDIATE RELEASE INNOPHOS ENTERS INTO EXPANDED $450 MILLION SENIOR SECURED BANK CREDIT FACILITY CRANBURY, New Jersey ? (December 22, 2016) ? Innophos Holdings, Inc. (NASDAQ: IPHS) today announced t |
|
| December 22, 2016 |
EX-10.1 Exhibit 10.1 Published CUSIP Number: 45778EAD6 45778EAE4 CREDIT AGREEMENT among INNOPHOS HOLDINGS, INC., as the Company, CERTAIN DOMESTIC SUBSIDIARIES OF THE COMPANY FROM TIME TO TIME PARTY HERETO, as Subsidiary Borrowers, CERTAIN DOMESTIC SUBSIDIARIES OF THE COMPANY FROM TIME TO TIME PARTY HERETO, as Guarantors, THE LENDERS PARTY HERETO, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Admi |
|
| December 22, 2016 |
Innophos Holdings FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 22, 2016 (December 22, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdictio |
|
| October 31, 2016 |
Innophos Holdings 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Num |
|
| October 27, 2016 |
EX-99.1 2 q316iphsearningsprfinal.htm Q3 2016 FINANCIAL RESULTS FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS THIRD QUARTER 2016 RESULTS Strong and Consistent Earnings Performance Improved Margin Profile and Strong Cash Generation Announces Strategic Two-year Tolling Agreement for GTSP Co-Product Business CRANBURY, New Jersey – (October 27, 2016) – Innophos Holdings, Inc. (NASDAQ: IPHS), t |
|
| October 27, 2016 |
Financial Statements and Exhibits, Other Events Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 27, 2016 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) ( |
|
| August 2, 2016 |
Financial Statements and Exhibits, Other Events Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 2, 2016 (August 1, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or oth |
|
| August 2, 2016 |
Exhibit FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS SECOND QUARTER 2016 RESULTS CRANBURY, New Jersey ? (August 1, 2016) ? Innophos Holdings, Inc. (NASDAQ: IPHS), today announced its financial results for the second quarter 2016. Highlights ? Adjusted EBITDA of $30 million and margin of 17% both in line with the first quarter 2016 as expected, with a year-over-year margin improvement of 1 |
|
| August 2, 2016 |
Innophos Holdings 10-Q (Quarterly Report) 10-Q 1 iphs10q063016.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| August 1, 2016 |
Financial Statements and Exhibits, Other Events 8-K 1 form8-k2016q2earnings.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 1, 2016 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdi |
|
| August 1, 2016 |
EX-99.1 2 q216earningsprfinal.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS SECOND QUARTER 2016 RESULTS CRANBURY, New Jersey – (August 1, 2016) – Innophos Holdings, Inc. (NASDAQ: IPHS), today announced its financial results for the second quarter 2016. Highlights • Adjusted EBITDA of $30 million and margin of 17% both in line with the first quarter 2016 as expected, with a |
|
| June 29, 2016 |
Termination of a Material Definitive Agreement 8-K 1 a8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 29, 2016 (June 23, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdict |
|
| May 23, 2016 |
EXHIBIT 24 Innophos Holdings, Inc. Amy Hartzell POA EXHIBIT 24 Innophos Holdings, Inc. Power of Attorney for Executing Forms 3, 4 and 5 Know all men by these presents, that the undersigned, director or officer, or both, of Innophos Holdings, Inc., hereby constitutes and appoints each of /s/ Joshua Horenstein, /s/ Michael Lestino, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of |
|
| May 17, 2016 |
Submission of Matters to a Vote of Security Holders SEC Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 16, 2016 (May 13, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of i |
|
| April 29, 2016 |
Innophos Holdings 10-Q (Quarterly Report) 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 28, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 form8-kearnings2.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 27, 2016 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction |
|
| April 28, 2016 |
Exhibit FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS FIRST QUARTER 2016 RESULTS CRANBURY, New Jersey ? (April 27, 2016) ? Innophos Holdings, Inc. (NASDAQ: IPHS), today announced its financial results for the first quarter 2016. Highlights ? Adjusted EBITDA of $31 million, in line with first quarter 2015, and up 39% sequentially, resulting in a margin of 17%, up 90 basis points compared to |
|
| April 13, 2016 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defi |
|
| April 6, 2016 |
8-K 1 form8-kltipawards.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 6, 2016 (April 1, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or ot |
|
| April 6, 2016 |
EXECUTIVE EMPLOYMENT AGREEMENT Exhibit EXECUTIVE EMPLOYMENT AGREEMENT AGREEMENT , dated April 1, 2016 (the ?Agreement?), by and between Innophos Holdings, Inc. |
|
| April 6, 2016 |
8-K 1 form8-kcfoappointment21.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 6, 2016 (April 1, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State |
|
| April 6, 2016 |
INNOPHOS HOLDINGS, INC. APPOINTS HAN KIEFTENBELD AS CHIEF FINANCIAL OFFICER EX-99.1 3 iphscfoappointment.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. APPOINTS HAN KIEFTENBELD AS CHIEF FINANCIAL OFFICER CRANBURY, New Jersey – (April 4, 2016) – Innophos Holdings, Inc. (NASDAQ: IPHS), today announced that its Board of Directors has appointed Han Kieftenbeld as Chief Financial Officer, effective April 1, 2016. Mark Feuerbach, the Company’s interim CFO, will |
|
| April 4, 2016 |
EXHIBIT 24 Innophos Holdings, Inc. Hermanus (Han) Kieftenbeld POA EXHIBIT 24 Innophos Holdings, Inc. Power of Attorney for Executing Forms 3, 4 and 5 Know all men by these presents, that the undersigned, director or officer, or both, of Innophos Holdings, Inc., hereby constitutes and appoints each of Joshua Horenstein, Michael Lestino, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on beh |
|
| March 30, 2016 |
8-K 1 a8k-louis.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 30, 2016 INNOPHOS HOLDINGS, INC. (exact names of registrants as specified on their charters) Delaware (states or other jurisdictions of incorporation) 001- |
|
| March 30, 2016 |
INNOPHOS HOLDINGS, INC. ANNOUNCES EXECUTIVE CHANGE EX-99.1 2 calvarindeparture.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. ANNOUNCES EXECUTIVE CHANGE CRANBURY, New Jersey – (March 30, 2016) – Innophos Holdings, Inc. (NASDAQ: IPHS), today announced that Louis Calvarin, Senior Vice President, Strategy and Chief Risk Officer, has left the Company after 30 years of dedicated service. “We thank Louis for his contributions over the ye |
|
| March 24, 2016 |
EXHIBIT 24 Innophos Holdings, Inc. Joshua S Horenstein POA EXHIBIT 24 Innophos Holdings, Inc. Power of Attorney for Executing Forms 3, 4 and 5 Know all men by these presents, that the undersigned, director or officer, or both, of Innophos Holdings, Inc., hereby constitutes and appoints each of Michael Lestino, Kim Ann Mink, Mark Feuerbach, Chuck Brodheim, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) ex |
|
| March 21, 2016 |
INNOPHOS HOLDINGS, INC. ANNOUNCES EXECUTIVE CHANGE Exhibit FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. ANNOUNCES EXECUTIVE CHANGE CRANBURY, New Jersey ? (March 21, 2016) ? Innophos Holdings, Inc. (NASDAQ: IPHS), today announced that it has initiated a search for a new Chief Legal Officer to succeed William Farran, Senior Vice President, Chief Legal Officer and Corporate Secretary, who has left the Company after 29 years of dedicated service. In |
|
| March 21, 2016 |
8-K 1 a8k-bill.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: March 15, 2016) INNOPHOS HOLDINGS, INC. (exact names of registrants as specified on their charters) Delaware (states or other jurisdictions of incorporation) 001-3 |
|
| February 26, 2016 |
Innophos Holdings 10-K (Annual Report) 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to INNOPHOS HOLDINGS, INC. |
|
| February 26, 2016 |
Exhibit 12.1 Calculation of Ratio of Earnings to Fixed Charges December 31, (dollars in thousands) 2015 2014 2013 2012 2011 Earnings Income before provision for income taxes $ 40,123 $ 97,356 $ 76,247 $ 105,973 $ 130,411 Plus: fixed charges (1) 9,869 6,617 7,583 8,099 7,812 $ 49,992 $ 103,973 $ 83,830 $ 114,072 $ 138,223 Fixed Charges: Gross interest expense 7,583 4,394 5,475 6,042 5,964 Estimate |
|
| February 26, 2016 |
SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. EXHIBIT 21.1 SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. Company Ownership* Jurisdiction Innophos Investments Holdings, Inc. Innophos Holdings, Inc. Delaware Innophos, Inc. Innophos Investments Holdings, Inc. Delaware Woody IV, LLC Innophos Investments Holdings, Inc. Utah Innophos Nutrition, Inc. Innophos, Inc. Delaware Innophos (Gibraltar) Investments Holdings Limited Innophos, Inc. Gibraltar Innopho |
|
| February 26, 2016 |
EXHIBIT 10.6 INNOPHOS MEXICANA S de RL DE CV Subgerencia Comercial Pemex Petroquímica Pios 237, Torre Ejec. Pemex Marina Nacional # 329 Col. Huasteca, CP 11311 Deleg. Miguel Hgo. Mexico, D.F. Attn. Ing. Jorge Aurelio Carrillo Careaga Gerente de Comercializacion PPQ REFERENCE: CORPORATE CONVERSION Date: FEBRUARY 22, 2011 I hereby wish to inform about the conversion of our company from Innophos Mexi |
|
| February 23, 2016 |
INNOPHOS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2015 RESULTS EX-99.1 2 q415earningsprfinal.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2015 RESULTS CRANBURY, New Jersey – (February 22, 2016) – Innophos Holdings, Inc. (NASDAQ: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, or |
|
| February 23, 2016 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 22, 2016 INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of incorporation) (Comm |
|
| February 12, 2016 |
OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0145 Estimated average burden hours per response. . . . . . . . . . .10.4 SCHEDULE 13G INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) (Amendment No. 6) INNOPHOS HOLDINGS, INC. (Name of Issuer) |
|
| February 10, 2016 |
IPHS / Innophos Holdings, Inc. / VANGUARD GROUP INC Passive Investment SC 13G/A 1 innophosholdingsinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5 )* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box to designate the rule pursu |
|
| February 9, 2016 |
8-K 1 form8-kxacommitteeassignme.htm 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 8, 2016 (January 11, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaw |
|
| February 9, 2016 |
EX-3.1 2 amendedandrestatedbylaws2-.htm AMENDED AND RESTATED BYLAWS OF INNOPHOS HOLDINGS, INC., AS AMENDED AND RESTATED BYLAWS OF INNOPHOS HOLDINGS, INC. A Delaware Corporation (Amended and Restated as of February 5, 2016) ARTICLE I OFFICES Section 1. Registered Office . The registered office of Innophos Holdings, Inc. (the “Corporation”) in the State of Delaware shall be located at 2711 Centervil |
|
| February 9, 2016 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 8, 2016 (February 5, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of in |
|
| January 29, 2016 |
INNOPHOS HOLDINGS, INC. ANNOUNCES BOARD OF DIRECTORS CHANGES EX-99.1 2 kimannminkboardelection.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. ANNOUNCES BOARD OF DIRECTORS CHANGES CRANBURY, New Jersey – (January 29, 2016) – Innophos Holdings, Inc. (NASDAQ: IPHS), today announced that Dr. Kim Ann Mink, Chief Executive Officer and President, has been appointed to the Board of Directors of Innophos, effective immediately. “We are pleased to form |
|
| January 29, 2016 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 29, 2016 (January 29, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of in |
|
| January 14, 2016 |
Exhibit COOPERATION AGREEMENT This Cooperation Agreement (this ? Agreement ?), dated January 11, 2016, is made by and among FrontFour Capital Group, LLC and the entities and natural persons listed on Exhibit A hereto (collectively, ? FrontFour ?) and Innophos Holdings, Inc. |
|
| January 14, 2016 |
Exhibit Innophos to Appoint Peter T. Thomas and Robert J. Zatta to Board of Directors Innophos and FrontFour Capital Announce Agreement CRANBURY, N.J., January 11, 2016 - Innophos Holdings, Inc. (NASDAQ: IPHS) (?Innophos? or the ?Company?) and FrontFour Capital Group LLC (?FrontFour Capital?), a shareholder of Innophos, with ownership of 1.07% of the Company?s outstanding shares, today announced t |
|
| January 14, 2016 |
Innophos Holdings 8-K COOPERATION AGREEMENT & PRESS RELEASE (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 14, 2016 (January 11, 2016) INNOPHOS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-33124 20-1380758 (State or other jurisdiction of in |
|
| January 8, 2016 |
IPHS / Innophos Holdings, Inc. / Neuberger Berman Group LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Innophos Holdings, Inc. (Name of Issuer) Common (Title of Class of Securities) 45774N108 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| December 4, 2015 |
8-K Date: December 4, 2015 Mr. Robert Harrer 928 Tennis Avenue Ambler, PA 19002 Re: Separation Agreement Dear Robert: As you and I have discussed, it is your desire to move to the next step in your career, and we share your desire to work out the terms of your separation from Innophos. Speaking for myself and the Board of Directors, we have enjoyed working with you and you have brought great insig |
|
| December 4, 2015 |
8-K 1 a8k-cfo.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: December 4, 2015) INNOPHOS HOLDINGS, INC. (exact names of registrants as specified on their charters) Delaware (states or other jurisdictions of incorporation) 001- |
|
| December 4, 2015 |
Innophos Appoints Mark Feuerbach Interim CFO 8-K FOR IMMEDIATE RELEASE Innophos Appoints Mark Feuerbach Interim CFO CRANBURY, N. |
|
| November 16, 2015 |
EXECUTIVE EMPLOYMENT AGREEMENT 8-K Execution Copy EXECUTIVE EMPLOYMENT AGREEMENT AGREEMENT , dated November 10, 2015 (this ?Agreement?), by and between Innophos Holdings, Inc. |
|
| November 16, 2015 |
8-K Mr. Randolph Gress Chairman, CEO & President Innophos Holdings, Inc. 259 Prospect Plains Road, Building A Cranbury, NJ 08512 Dear Randy, As you know, the Innophos Holdings, Inc. (?Company?) Board of Directors has been working with you on CEO succession planning over the course of several years. Speaking for the Board, I am gratified that you and the Board have reached mutual agreement on an ap |
|
| November 16, 2015 |
8-K 1 a8k-ceo11x15x15.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: November 10, 2015) INNOPHOS HOLDINGS, INC. (exact names of registrants as specified on their charters) Delaware (states or other jurisdictions of incorporat |
|
| November 16, 2015 |
Innophos Appoints Kim Ann Mink as Chief Executive Officer CEO Randy Gress Announces Plan to Retire 8-K FOR IMMEDIATE RELEASE Innophos Appoints Kim Ann Mink as Chief Executive Officer CEO Randy Gress Announces Plan to Retire CRANBURY, N. |
|
| November 4, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 iphs10q093015.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period |
|
| November 3, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: November 3, 2015) INNOPHOS HOLDINGS, INC. |
|
| November 3, 2015 |
8-K FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS THIRD QUARTER 2015 RESULTS IMPLEMENTS RESTRUCTURING PROGRAM TO ACHIEVE $13 MILLION COST SAVINGS CRANBURY, New Jersey ? (November 3, 2015) ? Innophos Holdings, Inc. (NASDAQ: ?IPHS?), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharma |
|
| August 7, 2015 |
SECOND AMENDMENT TO CREDIT AGREEMENT Innophos2015-SecondAmendmenttoCreditAgreement3 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this ? Amendment ?), dated as of August 7, 2015, is by and among INNOPHOS HOLDINGS, INC. |
|
| August 7, 2015 |
Entry into a Material Definitive Agreement 8-K 1 secondamendment8-kfinal.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: August 7, 2015) INNOPHOS HOLDINGS, INC. (exact names of registrants as specified on their charters) Delaware (states or other jurisdictions of incor |
|
| July 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 iphs10q063015.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| July 27, 2015 |
Innophos Holdings Q2-2015 (Current Report/Significant Event) 8KQ2-2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: July 27, 2015) INNOPHOS HOLDINGS, INC. |
|
| July 27, 2015 |
INNOPHOS HOLDINGS, INC. REPORTS SECOND QUARTER 2015 RESULTS EX-99.1 2 q215earningsprfinal.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS SECOND QUARTER 2015 RESULTS CRANBURY, New Jersey – (July 27, 2015) – Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and indu |
|
| May 27, 2015 |
Innophos Holdings 8-K (Current Report/Significant Event) 8-Kre2015ShareholderMeetingResults-5272015v2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 22, 2015 Innophos Holdings, Inc. |
|
| May 27, 2015 |
2015 Executive, Management and Sales Incentive Plan Innophos, Inc. Ex991-InnophosInc2015EMSIP EXHIBIT 99.1 2015 Executive, Management and Sales Incentive Plan Innophos, Inc. 1 Effective 1/1/2015 Purpose The Executive, Management and Sales Incentive Plan (?the Plan?) is designed to promote the interests of Innophos, Inc. and certain of its corporate affiliates (collectively, ?the Corporation?) by providing senior executives, managers and sales persons with incenti |
|
| May 13, 2015 |
8-K 1 a8-kre2015ltipawards.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2015 Innophos Holdings, Inc. (Exact name of Registrant as specified in its their Charter) Delaware (States or other jurisdictions of incorporat |
|
| April 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number |
|
| April 27, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: April 27, 2015) INNOPHOS HOLDINGS, INC. |
|
| April 27, 2015 |
INNOPHOS HOLDINGS, INC. REPORTS FIRST QUARTER 2015 RESULTS Q115EarningsPRFinal FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS FIRST QUARTER 2015 RESULTS CRANBURY, New Jersey ? (April 27, 2015) ? Innophos Holdings, Inc. (NASDAQ: ?IPHS?), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets, today a |
|
| April 21, 2015 |
Innophos Holdings DEFINITIVE PROXY STATEMENT DEF 14A 1 d881110ddef14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the C |
|
| February 19, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K 10-K 1 iphs10k123114.htm 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to INNOPHOS HOLDING |
|
| February 19, 2015 |
SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. EXHIBIT 21.1 SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. Company Ownership* Jurisdiction Innophos Investments Holdings, Inc. Innophos Holdings, Inc. Delaware Innophos, Inc. Innophos Investments Holdings, Inc. Delaware Woody IV, LLC Innophos Investments Holdings, Inc. Utah Innophos Nutrition, Inc. Innophos, Inc. Delaware Innophos (Gibraltar) Holdings Limited Innophos, Inc. Gibraltar Innophos (Gibraltar |
|
| February 19, 2015 |
Exhibit 12.1 Calculation of Ratio of Earnings to Fixed Charges December 31, (dollars in thousands) 2014 2013 2012 2011 2010 Earnings Income before provision for income taxes $ 97,356 $ 76,247 $ 105,973 $ 130,411 $ 66,488 Plus: fixed charges (1) 6,617 7,583 8,099 7,812 30,258 $ 103,973 $ 83,830 $ 114,072 $ 138,223 $ 96,746 Fixed Charges: Gross interest expense 4,394 5,475 6,042 5,964 28,618 Estimat |
|
| February 18, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: February 17, 2015) INNOPHOS HOLDINGS, INC. |
|
| February 18, 2015 |
INNOPHOS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2014 RESULTS EX-99 2 q414earningsprfinal.htm PRESS RELEASE FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2014 RESULTS CRANBURY, New Jersey – (February 17, 2015) – Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, o |
|
| February 13, 2015 |
OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0145 Estimated average burden hours per response. . . . . . . . . . .10.4 SCHEDULE 13G INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) (Amendment No. 5) Innophos Holdings, Inc. (Name of Issuer) |
|
| February 11, 2015 |
IPHS / Innophos Holdings, Inc. / Neuberger Berman Group LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Innophos Holdings, Inc. (Name of Issuer) Common (Title of Class of Securities) 45774N108 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| February 10, 2015 |
IPHS / Innophos Holdings, Inc. / VANGUARD GROUP INC Passive Investment innophosholdings.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate b |
|
| December 23, 2014 |
EX-99.2 3 sharebuyback201412pr.htm EXHIBIT FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. ANNOUNCES 2015 SHARE BUYBACK PROGRAM FOR $125 MILLION, OR APPROXIMATELY 10% OF ITS MARKET CAPITALIZATION, OVER THE NEXT 12 MONTHS CRANBURY, New Jersey – (December 22, 2014) – Innophos Holdings, Inc. (NASDAQ: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients, |
|
| December 23, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 18, 2014 Innophos Holdings, Inc. |
|
| December 23, 2014 |
FIRST AMENDMENT TO CREDIT AGREEMENT EXECUTION VERSION FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of December 18, 2014, is by and among INNOPHOS HOLDINGS, INC. |
|
| October 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Num |
|
| October 27, 2014 |
INNOPHOS HOLDINGS, INC. REPORTS THIRD QUARTER 2014 RESULTS EPS of $0.83 up 69% year-over-year EX-99.1 2 q314earningsprfinal.htm FINANCIAL STATEMENTS FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS THIRD QUARTER 2014 RESULTS EPS of $0.83 up 69% year-over-year CRANBURY, New Jersey – (October 27, 2014) – Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary su |
|
| October 27, 2014 |
Financial Statements and Exhibits, Other Events 8-K 1 a8kq3-2014.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: October 27, 2014) INNOPHOS HOLDINGS, INC. (exact names of registrants as specified on their charters) Delaware (states or other jurisdictions of incorporation) 0 |
|
| September 30, 2014 |
INNOPHOS HOLDINGS, INC. ELECTS JAMES ZALLIE TO BOARD OF DIRECTORS FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. ELECTS JAMES ZALLIE TO BOARD OF DIRECTORS CRANBURY, New Jersey – (September 30, 2014) – Innophos Holdings, Inc. (NASDAQ: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients, today announced the election of James (Jim) Zallie to its Board of Directors. Mr. Zallie is Executive Vice President Global Specia |
|
| September 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported: September 26, 2014) Innophos Holdings, Inc. |
|
| July 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 iphs10q063014.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| July 29, 2014 |
FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS SECOND QUARTER 2014 RESULTS EPS of $0.93 up 45% sequentially; Dividend increased 20% CRANBURY, New Jersey – (July 28, 2014) – Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral car |
|
| July 29, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: July 28, 2014) INNOPHOS HOLDINGS, INC. |
|
| May 27, 2014 |
Submission of Matters to a Vote of Security Holders - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 20, 2014 Innophos Holdings, Inc. |
|
| April 29, 2014 |
Financial Statements and Exhibits, Other Events 8-K 1 a8kq1pr-2014.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: April 28, 2014) INNOPHOS HOLDINGS, INC. (exact names of registrants as specified on their charters) Delaware (states or other jurisdictions of incorporation) 0 |
|
| April 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number |
|
| April 29, 2014 |
EX-99.1 3 q114earningsprfinal.htm PRESS RELEASE FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS FIRST QUARTER 2014 RESULTS Sales Up 10% Sequentially; Operating Income Up 22% Year-Over-Year CRANBURY, New Jersey – (April 28, 2014) – Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food |
|
| April 22, 2014 |
Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 3, 2014 |
8-K 1 a8-kre2014ltipawardsjat040.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 28, 2014 Innophos Holdings, Inc. (Exact name of Registrant as specified in its their Charter) Delaware (States or other jurisdictions of i |
|
| March 6, 2014 |
EX-3.1 2 exhibit3.htm EXHIBIT Exhibit 3.1 “The Board of Directors by resolution may permit the Chief Executive Officer to designate any one or more persons having supervisory or managerial authority over any unit, function or sector of the business of the Corporation with the title of vice president, assistant vice president or any similar or other title considered appropriate by the Chief Executi |
|
| March 6, 2014 |
INNOPHOS ELECTS ROBERT HARRER VICE PRESIDENT AND CHIEF FINANCIAL OFFICER EX-99.1 3 rhpressrelease.htm EXHIBIT FOR IMMEDIATE RELEASE Exhibit 99.1 INNOPHOS ELECTS ROBERT HARRER VICE PRESIDENT AND CHIEF FINANCIAL OFFICER CRANBURY, New Jersey – (March 3, 2014) – Innophos Holdings, Inc. (NASDAQ: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients, today announced that its Board of Directors has elected Robert Harrer as Vice |
|
| March 6, 2014 |
8-K 1 a20148-krecfoandbylaws0304.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2014 Innophos Holdings, Inc. (Exact name of Registrant as specified in its Charter) Delaware (States or other jurisdiction of incorpo |
|
| February 27, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K 10-K 1 iphs10k123113.htm 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to INNOPHOS HOLDING |
|
| February 27, 2014 |
SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. EX-21.1 3 iphs10k123113ex211.htm SUBSIDIARIES OF REGISTRANT EXHIBIT 21.1 SUBSIDIARIES OF INNOPHOS HOLDINGS, INC. Company Ownership* Jurisdiction Innophos Holdings, Inc. Delaware Innophos Investments Holdings, Inc. Innophos Holdings, Inc. Delaware Innophos Investments III, LLC Innophos Netherlands Investments Holdings C.V. Delaware Innophos, Inc. Innophos Investments II, Inc. Delaware Woody IV, LLC |
|
| February 27, 2014 |
Exhibit 12.1 Calculation of Ratio of Earnings to Fixed Charges December 31, (dollars in thousands) 2013 2012 2011 2010 2009 Earnings Income (loss) before provision for income taxes $ 76,247 $ 105,934 $130,411 $66,488 $104,346 Plus: fixed charges (1) 7,547 8,099 7,812 30,258 29,067 $ 83,794 $ 114,033 $138,223 $96,746 $133,413 Fixed Charges: Gross interest expense 5,475 6,042 5,964 28,618 27,354 Est |
|
| February 19, 2014 |
FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2013 RESULTS 4Q13 GAAP EPS $0.65; Up 16% Sequentially and Up 5% YOY versus Adjusted EPS CRANBURY, New Jersey – (February 18, 2014) – Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary s |
|
| February 19, 2014 |
Financial Statements and Exhibits, Other Events 8-K 1 a8kq4pr-20141.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported: February 18, 2014) INNOPHOS HOLDINGS, INC. (exact names of registrants as specified on their charters) Delaware (states or other jurisdictions of incorporatio |
|
| February 12, 2014 |
SC 13G 1 agi-innophosholdingsinc201.htm SC 13G OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0145 Estimated average burden hours per response. . . . . . . . . . .10.4 SCHEDULE 13G INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) (Amendment |
|
| February 12, 2014 |
IPHS / Innophos Holdings, Inc. / Neuberger Berman Group LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* Innophos Holdings, Inc. (Name of Issuer) Common (Title of Class of Securities) 45774N108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
| February 11, 2014 |
IPHS / Innophos Holdings, Inc. / VANGUARD GROUP INC Passive Investment innophos.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: Innophos Holdings Inc Title of Class of Securities: Common Stock CUSIP Number: 45774N108 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to de |
|
| October 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Num |
|
| October 28, 2013 |
FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS THIRD QUARTER 2013 RESULTS ANNOUNCES 14% INCREASE IN QUARTERLY DIVIDEND TO $0.40 PER SHARE CRANBURY, New Jersey – (October 28, 2013) – Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, |
|
| October 28, 2013 |
Financial Statements and Exhibits, Other Events 8-K 1 form8k102813.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported: October 28, 2013) Innophos Holdings, Inc. (Exact name of Registrant as specified in its their Charter) Delaware (States or other jurisdictions of incorporation |
|
| August 7, 2013 |
August 7, 2013 Mr. Terence O’Brien Accounting Branch Chief Division of Corporation Finance Securities and Exchange Commission Washington, D.C. 20549-4631 Re: Innophos Holdings, Inc. Form 10-K for Fiscal Year Ended December 31, 2012 Filed February 20, 2013 File No. 1-33124 Dear Mr. O’Brien: This letter acknowledges receipt of your letter dated July 10, 2013 addressed to Mr. Neil Salmon, the former |
|
| July 31, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0 |
|
| July 29, 2013 |
INNOPHOS HOLDINGS, INC. REPORTS SECOND QUARTER 2013 RESULTS EX-99.1 2 q213earningsprfinal.htm EXHIBIT FOR IMMEDIATE RELEASE INNOPHOS HOLDINGS, INC. REPORTS SECOND QUARTER 2013 RESULTS CRANBURY, New Jersey – (July 29, 2013) – Innophos Holdings, Inc. (NASDAQ: “IPHS”), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industria |
